- Investing Ideas
- French Pharmaceuticals & Biotech Buy the Dip
French Pharmaceuticals & Biotech Buy the Dip
Results
2
2 new
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
2 companies
MedinCell
Market Cap: €927.8m
A clinical-stage and commercial biopharmaceutical licensing company, develops long acting injectables in various therapeutic areas in France.
New
MEDCL
€25.50
7D
-8.4%
1Y
59.3%
Cellectis
Market Cap: €176.7m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
New
ALCLS
€2.37
7D
-12.4%
1Y
49.6%